Myopathy secondary to empagliflozin therapy in type 2 diabetes.
[Mitochondrial myopathy, deafness and type 2 diabetes mellitus with tRNALeu(UUR) point mutation in mitochondrial DNA].
The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients.
Farup J, Just J, de Paoli F, Lin L, Jensen JB, Billeskov T, Roman IS, Cömert C, Møller AB, Madaro L, Groppa E, Fred RG, Kampmann U, Gormsen LC, Pedersen SB, Bross P, Stevnsner T, Eldrup N, Pers TH, Rossi FMV, Puri PL, Jessen N.
Cell Metab. 2021 Nov 2;33(11):2201-2214.e11. doi: 10.1016/j.cmet.2021.10.001. Epub 2021 Oct 21.
Skeletal muscle mitochondrial remodeling in exercise and diseases.
Gan Z, Fu T, Kelly DP, Vega RB.
Cell Res. 2018 Oct;28(10):969-980. doi: 10.1038/s41422-018-0078-7. Epub 2018 Aug 14.
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction.
Lee SJ.
J Clin Invest. 2021 May 3;131(9):e148372. doi: 10.1172/JCI148372.
Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment.
Packer M.
Eur J Heart Fail. 2020 Feb;22(2):214-227. doi: 10.1002/ejhf.1646. Epub 2019 Dec 17.
The impact of type 2 diabetes on the development of tendinopathy.
Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3417. doi: 10.1002/dmrr.3417. Epub 2020 Nov 6.
Rehabilitation of Individuals With Diabetes Mellitus: Focus on Diabetic Myopathy.
Bassi-Dibai D, Santos-de-Araújo AD, Dibai-Filho AV, de Azevedo LFS, Goulart CDL, Luz GCP, Burke PR, Garcia-Araújo AS, Borghi-Silva A.
Front Endocrinol (Lausanne). 2022 Apr 14;13:869921. doi: 10.3389/fendo.2022.869921. eCollection 2022.
Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus.
Hou Y, Xiang J, Wang B, Duan S, Song R, Zhou W, Tan S, He B.
Front Endocrinol (Lausanne). 2024 Jan 8;14:1263650. doi: 10.3389/fendo.2023.1263650. eCollection 2023.
Skeletal Muscle and Metabolic Health: How Do We Increase Muscle Mass and Function in People with Type 2 Diabetes?
Al-Ozairi E, Alsaeed D, Alroudhan D, Voase N, Hasan A, Gill JMR, Sattar N, Welsh P, Gray CM, Boonpor J, Celis-Morales C, Gray SR.
J Clin Endocrinol Metab. 2021 Jan 23;106(2):309-317. doi: 10.1210/clinem/dgaa835.
Prevalence and consequences of musculoskeletal pain in the upper and lower extremities: A cross-sectional analysis of patients with type 1 and type 2 diabetes in Denmark.
Liaghat B, Folkestad L, Skou ST, Koes B, Hartvigsen J.
Prim Care Diabetes. 2023 Jun;17(3):267-272. doi: 10.1016/j.pcd.2023.02.003. Epub 2023 Mar 6.
Reduced Muscle Strength Is Associated With Insulin Resistance in Type 2 Diabetes Patients With Osteoarthritis.
Zaharia OP, Pesta DH, Bobrov P, Kupriyanova Y, Herder C, Karusheva Y, Bódis K, Bönhof GJ, Knitza J, Simon D, Kleyer A, Hwang JH, Müssig K, Ziegler D, Burkart V, Schett G, Roden M, Szendroedi J.
J Clin Endocrinol Metab. 2021 Mar 25;106(4):1062-1073. doi: 10.1210/clinem/dgaa912.
